Certara to Participate in Upcoming Investor Conferences
Certara (Nasdaq: CERT) said management will participate in three investor conferences in early March 2026: TD Cowen on March 3 at 3:10PM ET, Leerink Global Healthcare on March 9 at 8:00AM ET, and Barclays Global Healthcare on March 10 at 1:00PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (Nasdaq: CERT) said management will participate in three investor conferences in early March 2026: TD Cowen on March 3 at 3:10PM ET, Leerink Global Healthcare on March 9 at 8:00AM ET, and Barclays Global Healthcare on March 10 at 1:00PM ET.
Live webcasts will be available on Certara’s investor relations website and replays will be accessible for at least 90 days.
Details
News Market Reaction – CERT
On Feb 27, the day this news came out, CERT closed 4.12% above the previous close.
Data tracked by StockTitan Argus for the Feb 27 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- TD Cowen 46th Annual Health Care Conference
Date and Time: Tuesday, March 3rd, 2026, at 3:10PM ET
- Leerink Global Healthcare Conference
Date and Time: Monday, March 9th, 2026, at 8:00AM ET
- Barclays 28th Annual Global Healthcare Conference
Date and Time: Tuesday, March 10th, 2026, at 1:00PM ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Visit us at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.